8-chloroadenosine-3',5'-cyclic monophosphorothioate and probenecid

8-chloroadenosine-3',5'-cyclic monophosphorothioate has been researched along with probenecid in 1 studies

Compound Research Comparison

Studies (8-chloroadenosine-3',5'-cyclic monophosphorothioate)	Trials (8-chloroadenosine-3',5'-cyclic monophosphorothioate)	Recent Studies (post-2010) (8-chloroadenosine-3',5'-cyclic monophosphorothioate)	Studies (probenecid)	Trials (probenecid)	Recent Studies (post-2010) (probenecid)
17	0	1	3,664	292	375

Protein Interaction Comparison

Protein	Taxonomy	probenecid (IC50)
Solute carrier family 22 member 8	Mus musculus (house mouse)	3.02
Solute carrier family 22 member 6	Homo sapiens (human)	6.85
Solute carrier family 22 member 8	Homo sapiens (human)	6.965
Solute carrier family 22 member 8	Rattus norvegicus (Norway rat)	6.03

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christie, MJ; Hack, SP; Vaughan, CW	1

Other Studies

1 other study(ies) available for 8-chloroadenosine-3',5'-cyclic monophosphorothioate and probenecid

Article	Year
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology, 2003, Volume: 45, Issue:5 Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines	2003

Article

Year

Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.

Neuropharmacology, 2003, Volume: 45, Issue:5

Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines

2003